Who has invested in NEUROPHET?

GVA Asset Management, Findvalue Asset Management, Orion Capital Management are named among the investors backing NEUROPHET.

NEUROPHET Funding: $24M Raised, Series C (2023)

NEUROPHET funding overview

NEUROPHET is based in Seoul, South Korea. NEUROPHET has raised $24M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in November 2023. The round record for NEUROPHET runs through 2023; nothing later has been disclosed. Investors on record include GVA Asset Management, Findvalue Asset Management, Orion Capital Management. 3 distinct backers are named across the disclosed rounds.

NEUROPHET at a glance

Total raised: $24M
Latest round: Series C
Latest round date: November 2023
Headquarters: Seoul, South Korea
Notable investors: GVA Asset Management, Findvalue Asset Management, Orion Capital Management

Frequently asked about NEUROPHET funding

How much has NEUROPHET raised?: NEUROPHET has raised $24M in total disclosed funding across the rounds on record.
Who has invested in NEUROPHET?: GVA Asset Management, Findvalue Asset Management, Orion Capital Management are named among the investors backing NEUROPHET.
What was the latest NEUROPHET funding round?: The most recent disclosed round is a Series C, announced in November 2023.
Where is NEUROPHET based?: NEUROPHET is based in Seoul, South Korea.
When did NEUROPHET last raise?: The last disclosed NEUROPHET round closed in November 2023 at Series C.

Round data for NEUROPHET is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seoul and backer lists below.

NEUROPHET Funding: $24M Raised, Series C (2023)

NEUROPHET funding overview

NEUROPHET at a glance

Frequently asked about NEUROPHET funding

Companies related to NEUROPHET (18)

Browse related funding lists (5)